NCT02411760
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
- Locations
-
- UT Southwestern Medical Center - Advanced Imaging Research Center Dallas, Texas, United States
Clinical trial condition
Breast Neoplasms
Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.
9,896 public trials
1,789 recruiting studies
Breast Neoplasms trial results
NCT02303366
- Conditions
- Bone Diseases, Bone Neoplasms, Breast Diseases, +6 more
- Locations
-
- Peter MacCallum Cancer Centre Melbourne, Victoria, Australia
Completed
Electronic Patient Reporting of Side Effects to Chemotherapy: A Cluster Randomized Controlled Trial
NCT02996201
- Conditions
- Adverse Event, Breast Diseases, Breast Neoplasms, +7 more
- Locations
-
Not specified
NCT02483767
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
- Locations
-
Not specified
Completed
Study of ASLAN001 in Combination With Capecitabine in MBC That Has Failed on Prior Trastuzumab
NCT02338245
- Conditions
- Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
- Locations
-
- Australia Western Australia, Australia
- Hong Kong Hong Kong
- New Zealand Christchurch, New Zealand
- New Zealand Tauranga, New Zealand
NCT02809404
- Conditions
- Adenocarcinoma, Breast Cancer, Breast Diseases, +19 more
- Locations
-
- Radboud university medical center Nijmegen, Netherlands
Completed
Breast Cancer Surveillance Consortium
NCT01831778
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
- Locations
-
- Group Health Cooperative Seattle, Washington, United States
NCT02625935
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
- Locations
-
- Florida Cancer Center Fort Myers, Florida, United States
- New England Cancer Specialists Scarborough, Maine, United States
- Center for Cancer and Blood Disorders Bethesda, Maryland, United States
- North Shore Hematology Oncology Assoaciates East Setauket, New York, United States
Completed
A Study of Clinical Outcomes for the NanoString® Technologies Prosigna™ Gene Signature Assay
NCT02395575
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
- Locations
-
- Institut Curie Paris, France
NCT00485953
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Bone Loss, +11 more
- Locations
-
- University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States